RISE - Reduce Sitting Time Among Breast Cancer Survivors
RISE - A Pilot Study to Reduce Sitting Time Among Breast Cancer Survivors
1 other identifier
interventional
21
1 country
1
Brief Summary
This 3-month study will test whether a program to reduce sitting time, for breast cancer survivors experiencing some physical limitations, can improve their physical function and other important aspects of quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 2, 2022
CompletedStudy Start
First participant enrolled
March 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2023
CompletedMay 12, 2023
May 1, 2023
1 year
February 9, 2022
May 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention rate of enrolled participants
Percent of participants returning for the 3 month measures
3 months
Secondary Outcomes (4)
4 meter walk test
3 months
30-second Sit-to-Stand Test
3 months
Timed Up and Go (TUG)
3 months
Patient Reported Measurement Information System - Physical Function
3 months
Study Arms (1)
Sit Less
EXPERIMENTALThe primary goal of the Sit Less arm is to reduce the total amount of time spent sitting each day and break up prolonged bouts of sitting.
Interventions
The Sit Less arm uses habit formation, social cognitive theory, and motivational interviewing techniques to support behavior change and includes: 1) 7 health coaching sessions to set personalized goals and review progress; 2) wearing an activPAL (thigh worn accelerometer that measures sitting time); 3) intervention tools to support behavior change (e.g., standing desk, wrist worn monitor).
Eligibility Criteria
You may qualify if:
- Breast cancer survivors (stages I-IV) at least 1 year post active treatment (e.g., chemotherapy, radiotherapy)
- Breast cancer was treated with chemotherapy, radiation, immunotherapy, and/or endocrine therapy
- self-report difficulties with physical function
- self-report low levels of moderate to vigorous physical activity
- self-report high levels of sitting time
You may not qualify if:
- medical condition that interferes with ability to safely stand or stay balanced
- other cancer diagnoses that occurred after their breast cancer diagnosis
- Stage IV breast cancer with brain metastases or less than 12 months life-expectancy
- unable to commit to a 3-month study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moores UCSD Cancer Center
La Jolla, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 9, 2022
First Posted
March 2, 2022
Study Start
March 29, 2022
Primary Completion
April 7, 2023
Study Completion
May 7, 2023
Last Updated
May 12, 2023
Record last verified: 2023-05